Features Screener Stocks Charts
Sign In Sign Up

Amrutanjan Health Care Limited Cash Flow Statement

NSE:AMRUTANJAN | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

Cash Flow Insights

Cash Conversion

0.74x

AMRUTANJAN's operating cash flow covered 74% of net income in FY 2025. Some earnings may be tied up in working capital.

Free Cash Flow

₹153.46M

AMRUTANJAN's free cash flow was ₹153.46M in FY 2025, down 27.6% from FY 2024.

Dividend Coverage

1.2x

AMRUTANJAN's free cash flow covered dividends 1.2x in FY 2025 but leaves limited surplus.

CapEx Intensity

69.8%

Capital expenditure consumed 69.8% of operating cash flow in FY 2025 for AMRUTANJAN, typical of capital-intensive industries.

2-year AMRUTANJAN cash flow snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Net Income 619.46M 691.34M
Cash flow Operating Activities 279.09M 508.99M
Investments in PPE -67.17M -355.53M
Cash flow Investing Activities 191.66M -309.66M
Dividend Paid -133.86M -132.67M
Cash flow Financing Activities -482.66M -134.90M
Cash at beginning of period 49.03M 37.12M
Cash at end of period 37.12M 101.55M
Free Cash Flow 211.92M 153.46M

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025